STEW

SRH Total Return Fund, Inc.

NYSE · CIK 0000102426
$17.76 +0.23% $20.3B
Vol
Market Cap$20.3B
Cap SizeLarge Cap
Inst. Holders26 funds
Inst. Value$76.7M
Inst. Activity2 buys / 1 sells
Insider Activity1B / 0S
Insider Net $$87.7K
Exchange NYSE·CIK 0000102426·Prev Close $17.72

Recent Activity

May 21, 2026 Insider
Hemmer Jacob E bought 5,000 shares
Director @ $17.53 ($87.7K)
Inst.
WOLVERINE ASSET MANAGEMENT LLC — DOUBLED
93,534 shares ($1.6M)
Inst.
Allworth Financial LP — DOUBLED
508 shares ($8.7K)

Top Institutional Holders

FundValueMove
MORGAN STANLEY$37.0M
Allspring Global Investments Holdings,$12.3M
BANK OF AMERICA CORP$4.8MADD
RAYMOND JAMES FINANCIAL INC$3.8M
ROYAL BANK OF CANADA$2.9M

Recent Insider Trades

DateInsiderTypeValue
May 21, 2026Hemmer JacobBUY$87.7K
26 institutional holders with $76.7M total value (4,487,481 shares) as of 2026-Q1. Top holders: MORGAN, Allspring, BANK. Net buying activity: 2 institutions added/increased vs 1 reduced.

Top Institutional Holders — 2026-Q1

#FundSharesValue% of TrackedLast Move
1MORGAN STANLEY2,166,650$37.0M48.3%
2Allspring Global Investments Holdings, LLC721,643$12.3M16.1%
3BANK OF AMERICA CORP /DE/278,867$4.8M6.2%ADD +55.0%
4RAYMOND JAMES FINANCIAL INC222,619$3.8M5.0%
5ROYAL BANK OF CANADA170,172$2.9M3.8%
6WELLS FARGO & COMPANY/MN151,751$2.6M3.4%TRIM -26.0%
7CAPSTONE INVESTMENT ADVISORS, LLC111,819$1.9M2.5%
8HighTower Advisors, LLC107,147$1.8M2.4%
9ENVESTNET ASSET MANAGEMENT INC106,748$1.8M2.4%
10WOLVERINE ASSET MANAGEMENT LLC93,534$1.6M2.1%DOUBLED +162.2%
11D.A. DAVIDSON & CO.83,645$1.4M1.9%
12&PARTNERS78,243$1.3M1.7%DOUBLED +146.2%
13Independent Advisor Alliance60,360$1.0M1.3%
14STIFEL FINANCIAL CORP36,324$621.1K0.8%
15GUGGENHEIM CAPITAL LLC20,266$346.5K0.5%
16COMMONWEALTH EQUITY SERVICES, LLC17,635$301.6K0.4%TRIM -53.2%
17Waverly Advisors, LLC15,252$260.8K0.3%
18NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO12,550$214.6K0.3%
19JONES FINANCIAL COMPANIES LLLP12,212$202.7K0.3%
20CITADEL ADVISORS LLC10,124$173.1K0.2%

Recent Position Changes

FundActionPrev SharesCurr SharesChange %ValueQuarter
WOLVERINE ASSET MANAGEMENT LLCDOUBLED35,67093,534+162.2%$1.6M2026-Q1
Allworth Financial LPDOUBLED8508+6250.0%$8.7K2026-Q1
PNC FINANCIAL SERVICES GROUP, INC.NEAR_EXIT4,774220-95.4%$3.8K2026-Q1
WELLS FARGO & COMPANY/MNTRIM205,549152,079-26.0%$2.8M2025-Q4
&PARTNERSDOUBLED28,96771,329+146.2%$1.3M2025-Q4
WOLVERINE ASSET MANAGEMENT LLCTRIM54,35135,670-34.4%$661.3K2025-Q4
WOLVERINE ASSET MANAGEMENT LLCADD39,95854,351+36.0%$987.0K2025-Q3
WOLVERINE ASSET MANAGEMENT LLCTRIM156,10339,958-74.4%$706.5K2025-Q2
Walleye Capital LLCTRIM44,55611,433-74.3%$202.1K2025-Q2
PNC FINANCIAL SERVICES GROUP, INC.TRIM13,4756,925-48.6%$122.4K2025-Q2
BANK OF AMERICA CORP /DE/ADD161,699250,689+55.0%$4.3M2025-Q1
WOLVERINE ASSET MANAGEMENT LLCTRIM288,883156,103-46.0%$2.7M2025-Q1
UBS Group AGADD89,836119,518+33.0%$2.1M2025-Q1
PNC FINANCIAL SERVICES GROUP, INC.DOUBLED6,41013,475+110.2%$215.9K2024-Q4
PNC FINANCIAL SERVICES GROUP, INC.DOUBLED2,7356,410+134.4%$101.3K2024-Q3
COMMONWEALTH EQUITY SERVICES, LLCTRIM44,54020,830-53.2%$329.002024-Q3
1 unique insiders with 1 transactions. Net insider value: $87.7K ($87.7K bought, $0.00 sold).

Insider Transactions

DateInsiderTitleTypeSharesPriceValue
May 21, 2026Hemmer Jacob EDirectorBUY5,000$17.53$87.7K

No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.

No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.

Earnings Estimates & Revisions

PeriodEPS AvgEPS LowEPS HighEPS Growth30d Rev.Up/DownRev. AvgRev. GrowthAnalysts
Current Q
$0.00 $0.00 $0.00 $0.0B
Next Q
$0.00 $0.00 $0.00 $0.0B
Current FY
$0.00 $0.00 $0.00 $0.0B
Next FY
$0.00 $0.00 $0.00 $0.0B

No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.

No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.

No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.